Prognostic Factors for 100 Patients With Malignant Pleural Mesothelioma

dc.authoridGonlugur, Ugur/0000-0001-8720-2788
dc.contributor.authorGonlugur, Ugur
dc.contributor.authorGonlugur, Tanseli Efeoglu
dc.date.accessioned2025-01-27T20:43:39Z
dc.date.available2025-01-27T20:43:39Z
dc.date.issued2010
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractThe aim of this study was to investigate the effects of various clinical, laboratory characteristics, and therapeutic modalities on the survival of patients with malignant pleural mesothelioma. One hundred consecutive patients with a pathologically proven diagnosis of malignant pleural mesothelioma treated between 1993 and 2005 were included in the study. Using a Cox proportional hazard model, comorbidity, weight loss, breathlessness, and performance status were identified as independent prognostic factors. Comorbidity had interestingly favorable effect on the survival. Treated patients with chemotherapy had significantly longer survival than those treated with best supportive care. However, it was necessary to complete at least 6 cycles for a survival benefit. In conclusions, comorbidity information should be recorded in the recent prognostic studies. The drugs used for the comorbidity may improve survival.
dc.identifier.doi10.1080/19338240903390271
dc.identifier.endpage69
dc.identifier.issn1933-8244
dc.identifier.issue2
dc.identifier.pmid20439224
dc.identifier.scopus2-s2.0-77952231660
dc.identifier.scopusqualityQ2
dc.identifier.startpage65
dc.identifier.urihttps://doi.org/10.1080/19338240903390271
dc.identifier.urihttps://hdl.handle.net/20.500.12428/24317
dc.identifier.volume65
dc.identifier.wosWOS:000278130800003
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherHeldref Publications
dc.relation.ispartofArchives of Environmental & Occupational Health
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectpleural neoplasms
dc.subjectprognosis
dc.subjectsurvival analysis
dc.subjecttherapy
dc.titlePrognostic Factors for 100 Patients With Malignant Pleural Mesothelioma
dc.typeArticle

Dosyalar